Pharma VC Funds

Quake Capital, founded in 2016, is a venture capital firm and accelerator headquartered in Seattle, Washington, with a strong presence in New York and Los Angeles. The firm focuses on seed-stage investments, offering substantial support to new and early-stage ventures across a wide range of industries. Through their accelerator program, Quake Capital provides startups with resources, mentorship, and funding to help them grow and succeed. The firm has made over 300 investments in various sectors, including digital health, fintech, AR/VR, gaming, and e-commerce. Notable portfolio companies include NOCD, which offers online therapy for OCD; Blok Party, a platform combining physical, digital, and social play; Vyrill, a user-generated video content discovery and marketing platform; and Grain, which helps individuals build credit through savings. Quake Capital's investment strategy is industry-agnostic, emphasizing innovation and potential for growth. They typically invest $100,000 to $150,000 in each startup that completes their accelerator program. The firm’s founders, Glennon Argenbright, Chad Burgess, Adam Cragg, and Brandon Maier, bring extensive experience in venture capital and entrepreneurship, providing valuable insights and support to their portfolio companies.

Qualcomm Ventures, founded in 2000, is the corporate venture capital arm of Qualcomm Incorporated, headquartered in San Diego, California. The firm focuses on investing in early to growth-stage companies in sectors such as artificial intelligence (AI), automotive, mobile, enterprise and cloud, and smart systems. It supports startups with strategic guidance, leveraging Qualcomm’s extensive technological expertise and global network. Notable investments from Qualcomm Ventures include companies like Cloudflare, Xiaomi, Zoom, and SentinelOne. These companies have achieved significant milestones, including successful IPOs and high-profile acquisitions. For instance, SentinelOne went public in June 2021, and Zoom became a key player in cloud video conferencing and communication services. Qualcomm Ventures manages over $2 billion in assets and has a portfolio of more than 360 companies, with 22 unicorns and 19 companies that have gone public. The firm is also active in fostering innovation through specific funds like the Qualcomm Ventures AI Fund and the 5G Ecosystem Fund, which target emerging technologies in AI, machine learning, and 5G solutions. The investment team is composed of experienced professionals located in various global regions, including the US, China, and Israel, ensuring a broad and strategic reach to identify and support high-potential startups worldwide​.

Quantonation is a pioneering venture capital fund focused on early-stage investments in quantum technologies and deep physics. Founded in 2018, the Paris-based fund is dedicated to supporting startups working in quantum computing, quantum communications, quantum sensing, and related fields, aiming to accelerate the commercial adoption of groundbreaking scientific innovations. With over €91 million raised in its first fund, Quantonation has backed more than 30 companies, including notable names like Pasqal, ORCA Computing, and Qubit Pharmaceuticals. The fund's strategy targets startups at the pre-seed and seed stages, emphasizing those with the potential to transition quantum innovations into practical, industry-ready applications. These companies address critical areas such as molecular design, high-performance computing, and cybersecurity, with broader impacts expected in fields like healthcare, energy, and climate change mitigation. Quantonation leverages its deep scientific expertise and global network of research institutions, including partnerships with MIT, Ecole Polytechnique, and Oxford University. Quantonation has recently launched its second fund, Quantonation II, with a target of €200 million, signaling its commitment to expanding its support for quantum startups worldwide. Led by a team of experienced scientists and investors like Christophe Jurczak and Olivier Tonneau, the firm is actively shaping the future of the quantum tech ecosystem.

Quest Ventures is a leading venture capital firm focused on driving the digital economy across Asia. Founded in 2011 by James Tan and Wang Yunming, Quest Ventures invests primarily in early-stage startups within sectors such as artificial intelligence, e-commerce, fintech, logistics, media, and more. The firm is renowned for being one of the first investors in many startups, providing the critical early funding that enables these companies to scale and disrupt their industries. With its headquarters in Singapore and a significant presence in Southeast Asia, Quest Ventures has supported over 100 companies, including notable names like Carousell, ShopBack, 99.co, and StyleTheory. The firm's investment strategy includes thematic funds such as the Asia Fund, Metaverse Fund, and Decarbonisation Fund, focusing on areas like Web 3.0 technologies and environmental sustainability. Quest Ventures also operates investment syndicates, allowing accredited investors to participate in funding rounds of promising startups. This approach has enabled Quest Ventures to build a robust network of mentors, executives, and investors who provide strategic support and market insights to portfolio companies.

Quiet Capital, founded in 2017 and based in San Francisco, is a technology-focused venture capital firm. They invest in early-stage companies, spanning sectors such as fintech, software, cybersecurity, health and wellness, and AI. Their diverse portfolio includes notable companies like MoonPay, DuckDuckGo, Mercury, Reddit, and Substack. Quiet Capital typically invests from pre-seed to Series D stages, aiming to support remarkable founders from day zero. They have made 263 investments and achieved 11 notable exits, including Reddit and Atom Finance. Their investment strategy is centered on backing innovative technologies and scalable business models across a variety of industries. The firm is managed by a team of experienced partners including Ben Mahdavi, Co-Founder and Managing Partner, and Christopher Capozzi, Partner and CFO. They are known for their hands-on approach, providing strategic support and leveraging their extensive network to help portfolio companies grow. For startups looking to engage with Quiet Capital, demonstrating strong innovation, scalability, and a clear market need is essential. Connecting through their network or via their platform can improve the chances of securing investment.

R/GA Ventures is the investment and innovation arm of R/GA, a global digital agency. Founded in 2013, the firm supports early-stage startups through accelerator programs and offers financial, creative, and relationship capital. Notable investments include Latch, Happy Returns, and Transmit.Live. R/GA Ventures focuses on sectors such as IoT, commerce, retail, marketing tech, sports, and media tech. Their unique approach includes connecting startups with R/GA's extensive global network, providing strategic guidance and resources to help startups scale and succeed.

R42 Group is a venture capital firm based in Stanford, California, with a focus on deep science, artificial intelligence, and biotechnology. Established by Dr. Ronjon Nag, a seasoned AI entrepreneur with exits to companies like Motorola and Apple, R42 primarily invests in early-stage companies and supports them through a unique combination of financial backing and expert advisory. R42 has a hands-on approach, working closely with founders from the concept stage to growth, helping them build sustainable, impactful businesses in emerging fields such as AI, longevity, and deep tech. R42's portfolio includes companies such as Fountain Therapeutics, Healx, and Rubedo Life Sciences, all of which are innovating within the biotech and life sciences spaces. The firm also invests in early-stage funds that align with its values and frequently co-invests alongside these funds in promising startups. With a strong team of experts, including academics and industry veterans, R42 provides more than just capital—it offers strategic guidance, mentorship, and deep technical expertise to help companies succeed in highly specialized markets. In addition to investing, R42 runs the R42 Institute, which focuses on educating entrepreneurs and the broader community on AI, biotechnology, and longevity. Through its educational programs and investment strategies, R42 is committed to shaping the future of science and technology​.

RA Capital Management is a Boston-based venture capital and investment firm focused primarily on healthcare and life sciences. Founded in 2002, the firm invests across multiple stages, from seed funding to IPO, in companies developing drugs, medical devices, diagnostics, and research tools. RA Capital is known for its deep scientific and market expertise, facilitated by its internal research division, TechAtlas, which provides insights into competitive landscapes and helps guide investment decisions. The firm supports startups through its RAVen incubator, offering resources beyond capital, including strategic guidance, technology transfer, and executive recruitment. RA Capital has a strong commitment to innovation in human health, working closely with academics, entrepreneurs, and executives to bring groundbreaking therapies and technologies to market. Some notable portfolio companies include Moderna, Natera, and Peloton Therapeutics. RA Capital’s approach emphasizes evidence-based investing, focusing on creating value through informed decision-making and long-term growth.

Raba Capital, also known as The Raba Partnership, is a venture capital firm focused on early-stage investments in software and internet companies within the African technology ecosystem. Established in 2019 and headquartered in Cape Town, South Africa, Raba Capital aims to partner early with founders to help them build companies that solve real-world problems and generate significant returns. Notable investments in their portfolio include Flutterwave, a payment processing solution that became a unicorn in 2021, and Yoco, a merchant payments platform based in South Africa. Other significant investments include Lori Systems, a logistics marketplace, and Twiga, a digital grocery platform. Raba Capital focuses heavily on fintech, logistics, and healthcare sectors. They have invested in companies such as Stitch, which provides API infrastructure for fintechs, and 54gene, which leverages African DNA for medical discoveries. The firm prides itself on aligning long-term interests with their partners and leveraging their extensive network to support portfolio companies in scaling their businesses globally.

Rachel Zoe Ventures is an early-stage venture capital firm with a focus on disruptive consumer brands and the technologies that enable them. Led by fashion icon and entrepreneur Rachel Zoe, alongside her husband Rodger Berman, the firm leverages their vast experience in the media, fashion, and tech industries to help innovative consumer startups thrive. The firm is highly involved in amplifying the brands it backs, providing not just capital but also access to a vast network and strategic guidance on scaling brand recognition and growth. The firm has made key investments in brands such as Angel City FC, Joy, Havenly, and Citizen, all of which represent the type of forward-thinking, consumer-oriented companies Rachel Zoe Ventures seeks. Their portfolio demonstrates a strong emphasis on fashion, lifestyle, and tech-enabled consumer platforms. While primarily U.S.-focused, their influence and partnerships extend globally, especially in the consumer tech space. Rachel Zoe Ventures typically leads early-stage rounds and prefers to work with brands that are ready to scale their operations and disrupt their industries. The firm’s approach prioritizes partnerships with brands that align with its founders’ expertise in fashion, lifestyle, and media. Startups looking to engage with the firm should come prepared with a clear growth story and a compelling narrative that can stand out in today’s crowded consumer market.

Radical Ventures is a venture capital firm specializing in AI-driven startups that are poised to reshape various industries. Founded by AI pioneers, the firm is headquartered in Toronto with additional offices in Palo Alto, London, and New York. Radical Ventures focuses on investing in early-stage companies that leverage artificial intelligence to create transformational solutions. Their portfolio includes innovative companies like Waabi, which is developing next-generation self-driving technology, and Cohere, which works on advanced natural language processing. Other notable investments include Aspect Biosystems in biotechnology, ClimateAi for climate planning, and Signal 1, which provides real-time insights to healthcare providers. Radical Ventures emphasizes supporting their portfolio companies through the Radical Velocity program, which offers curated resources, expert support, and strategic partnerships to help AI-first startups scale effectively. This program covers areas such as talent acquisition, compute and technology needs, brand and public affairs, go-to-market strategies, and finance and governance. The firm's mission is to support founders who understand the profound impact AI will have on the future, aiming to drive significant advancements in sectors like healthcare, transportation, financial services, and more.

Radicle Growth, now operating as Clay Capital, is a venture capital firm focused on early-stage investments in agriculture and food technologies. Founded in San Diego, California, Radicle Growth aims to identify and support innovative entrepreneurs and technologies that can transform the food system. They frequently collaborate with global industry leaders to host challenges that fund groundbreaking agtech and foodtech startups. Notable investments by Radicle Growth include MycoTechnology, BlueNalu, Pluton Biosciences, and Phospholutions. MycoTechnology, a pioneer in fungal fermentation, won the $1 million growth-stage investment in the Radicle Protein Challenge by Syngenta. BlueNalu, focused on cell-based seafood, secured a $250,000 early-stage investment in the same challenge. Pluton Biosciences and Phospholutions were the winners of the Radicle Carbon & Soil Challenge by UPL, receiving $1 million and $250,000 respectively, to advance their innovative solutions in carbon sequestration and sustainable phosphorus use. Radicle Growth’s strategy involves not only funding but also providing startups with access to their extensive network of agriculture experts and global connections to accelerate development and promote their technologies. The firm’s commitment to sustainable agriculture is reflected in its continuous efforts to drive innovation and support the development of climate-positive solutions in the food value chain.

Radius Ventures was a New York-based venture capital firm active from 1997 to 2024, focused exclusively on growth-equity and expansion-stage health and life sciences companies. Co-founded by Managing Partner Jordan S. Davis and Daniel C. Lubin, the firm took a domain-driven investment approach combined with a hands-on value-add model — pairing intellectual capital and strategic guidance with deep industry relationships to back companies transforming patient care, advancing medical innovation, and improving health outcomes. Over nearly three decades, Radius completed more than 40 portfolio investments and led rounds across medical devices, diagnostics, biopharmaceuticals, life science tools, healthcare services, and healthcare information technology. The firm realized 33 or more exits, including 3 IPOs and 21 acquisitions. Marquee outcomes include Conor Medsystems (IPO 2004, subsequently acquired by Johnson and Johnson in 2007 for $1.4 billion at $33.50 per share), Tactile Medical (IPO July 2016, ranked first in share-price performance among commercial-stage medtech IPOs for over two years), Tabula Rasa Healthcare (IPO September 2016, ranked first among commercial-stage healthcare IT and services IPOs for over two years), and BioStorage Technologies, acquired by Brooks Automation. The flagship Radius Venture Partners III, LP achieved top-quartile performance per the Cambridge Associates Q3 2024 Venture Capital Index. Radius formally wound down in 2024 after the final portfolio exit, EndoGastric Solutions, in July of that year. Jordan Davis now leads JSD Capital LLC advising successor vehicles, while Daniel Lubin serves as Chairman of Upsher Management Company. The firm's nearly three-decade track record stands as one of the most consistent records in dedicated health and life-sciences growth equity.

Raed Ventures is a leading early-stage venture capital firm based in Saudi Arabia, focusing on transformative tech startups across the MENA region. Established in 2015 by Omar Almajdouie and Talal Alasmari, the firm aims to back companies that disrupt traditional industries with innovative technologies. Raed Ventures’ portfolio includes over 20 fast-growing startups, such as Mrsool, Foodics, and Trella, spanning sectors like logistics, fintech, and data analytics. Raed Ventures actively leads seed and Series A rounds, particularly favoring businesses with scalable tech solutions. Their strategy goes beyond funding; they offer extensive operational support through the Raed Plus platform, providing startups with access to partnerships, discounted services, and expert advisory, saving founders up to $400,000 in costs. The firm is particularly keen on startups that drive financial inclusion, digital transformation, and operational efficiencies across industries in MENA. With an average check size undisclosed, Raed Ventures focuses on companies with strong founding teams and market potential. They are a go-to VC for entrepreneurs looking to gain traction in the region, thanks to their hands-on approach, deep industry connections, and expertise in scaling businesses. Founders looking to approach Raed Ventures should come with a clear vision for regional growth and technological impact. Key figures include Omar Almajdouie, who leads with over 17 years of experience, and Talal Alasmari, known for his expertise in team building and product design. Raed Ventures operates primarily out of Riyadh, making it a cornerstone in the Saudi and wider MENA tech ecosystem.

Rainfall Ventures is a founder-focused venture capital firm with a strong presence in New York and Los Angeles. Founded in 2011, the firm emphasizes partnering with innovative and passionate founders to help them transform industries. Rainfall Ventures typically invests in early-stage companies, including pre-seed, seed, and Series A rounds, with investment sizes ranging from $1 million to $5 million​. The firm focuses on a broad range of sectors such as analytics, AI, cloud infrastructure, social media, cryptocurrency, cybersecurity, developer tools, digital health, education, fintech, gaming, IoT, and more. This diverse investment strategy allows Rainfall to support a variety of technological advancements and innovative business models. Rainfall Ventures has a portfolio that includes notable companies like Kyra and Blloc, and they invest globally with a particular focus on the US and the UK. The firm has built a reputation for not only providing capital but also offering extensive support to their portfolio companies through mentorship and strategic guidance. The team at Rainfall Ventures includes experienced professionals like co-founder and General Partner Ron Rofé, who bring a wealth of knowledge and expertise to their investment strategy.

Rally Ventures, founded in 2012, is a venture capital firm focused on early-stage investments in business technology. The firm operates out of Menlo Park, California, and Minneapolis, Minnesota. Rally Ventures invests in entrepreneurs creating new markets or bringing transformative approaches to existing ones, with a particular emphasis on sectors like AI/ML, cybersecurity, fintech, and SaaS+. Rally Ventures has a robust portfolio of notable investments, including companies like Arctic Wolf, Bugcrowd, Harness, UiPath, Total Expert, Braze, Carbon Black, and Twistlock. These companies represent Rally Ventures' strategic focus on high-potential business technology ventures that can drive significant market impact. The firm recently closed Rally Fund V at $240 million, continuing its legacy of investing in innovative early-stage startups. Rally Ventures has built a nationwide portfolio with over $1 billion in assets under management and a strong track record of successful exits, including three IPOs. The team at Rally Ventures includes a dynamic group of over 100 Rally Tech Partners—executives, technologists, and industry leaders—who provide strategic guidance and operational support to portfolio companies. This extensive network helps Rally Ventures offer significant value beyond just financial investment.

Rapid Pioneers is a venture capital and investment firm based in Berlin, Germany, focused on building and investing in innovative consumer brands that shape the future. They have a diverse portfolio that includes companies across sectors like e-commerce, technology, and sustainability. Some of their key investments include Enpal, a leader in solar power solutions, and Animoca Brands, a Hong Kong-based venture capital firm specializing in web3 technologies. They have also backed companies like Lesara, an agile fashion retail brand, and Amorelie, a premium online brand for intimate products. Rapid Pioneers supports companies from early stages, helping them scale through strategic partnerships and hands-on involvement. They tend to invest in businesses with high growth potential in both the digital and physical goods spaces. Their portfolio highlights a strong focus on digital innovation, with investments in mobile apps, blockchain technology, and direct-to-consumer brands. The firm has made several successful exits, including Fitvia, a direct-to-consumer wellness brand, and Casacanda, a home décor e-commerce platform that was acquired by Fab.com. Rapid Pioneers emphasizes sustainability and innovation, working with brands that have a community-first approach and a vision for a greener, tech-driven future.

Rarestone Capital is a Web3-focused venture capital and investment studio that specializes in supporting innovative blockchain projects. The firm plays an active role in backing startups within the decentralized finance (DeFi), gaming, and NFT spaces, leveraging its deep industry knowledge and resources to accelerate the development of these groundbreaking technologies. Rarestone takes an incubation-first approach, offering more than just capital—it provides hands-on support through Rarestone Labs, where startups can access strategic guidance, technical expertise, and a robust network of partners and advisors. Some of the notable projects in Rarestone’s portfolio include Biconomy, Injective Protocol, and Jito Network, all of which are trailblazers in the blockchain ecosystem. Rarestone is known for investing early, often leading seed and Series A rounds, and focusing on founders with a clear vision for decentralized technologies. Their portfolio companies typically work at the intersection of crypto infrastructure and user-centric applications, aiming to make blockchain technology more accessible and scalable. Based in the UK, Rarestone has a global reach, with a particular focus on projects that drive adoption of Web3 technologies. The firm is highly selective and prefers founders who are not only technically skilled but also capable of executing disruptive ideas within the Web3 space. Startups looking to partner with Rarestone should demonstrate strong technical innovation and a clear roadmap for scaling within the blockchain ecosystem.

Real Ventures is Canada’s leading early-stage venture capital firm, dedicated to supporting visionary founders from the very beginning of their entrepreneurial journey. Established in 2007, Real Ventures has invested in more than 200 startups across various sectors, particularly focusing on technology-driven industries. Their portfolio features high-growth companies like Clearco, Mejuri, and BenchSci, which reflect the firm’s commitment to empowering disruptive innovations. The firm focuses primarily on Canadian startups but also supports global growth. They invest in pre-seed to Series A rounds and are deeply involved in nurturing the founders they back. Real Ventures is also known for fostering ecosystems where their portfolio companies can thrive, including co-founding Montreal’s Notman House, a hub for tech entrepreneurs. Their strategy emphasizes conscious leadership, encouraging founders to develop their mindsets as they grow their businesses. The firm’s FounderFuel accelerator program further bolsters this approach by providing startups with mentorship, resources, and community support. Founders approaching Real Ventures should demonstrate not only business potential but also a commitment to making a positive societal impact. Key figures include founding partners John Stokes, Alan MacIntosh, and JS Cournoyer, all experienced entrepreneurs and investors who are deeply embedded in Canada’s startup ecosystem. Through hands-on involvement, Real Ventures helps founders build lasting companies with the potential to reshape industries and improve the world.

Real Tech Fund, established in 2015 and headquartered in Tokyo, Japan, is a venture capital firm focusing on seed and early-stage investments in deep tech companies. The fund primarily targets sectors such as high tech, aerospace, AI, life sciences, and IoT. Real Tech Fund is known for its strategic partnerships with organizations like the Ministry of Economy, Trade, and Industry, and NEDO (New Energy and Industrial Technology Development Organization), aiming to solve critical societal and environmental issues through innovation. The fund's notable investments include companies like ArkEdge Space, which focuses on satellite communication and space travel, and Integriculture, an agricultural technology firm. Real Tech Fund has invested heavily in Japan, but also extends its reach to other regions, including Southeast Asia. The firm has an average investment round size of $4 million and typically leads or co-invests in 8-10 deals per year. The team at Real Tech Fund comprises experienced partners such as Mitsuru Izumo and Jonathan Hannam, who bring a wealth of expertise in various tech and investment domains. Real Tech Fund's investment approach emphasizes supporting companies that leverage advanced technology to create impactful solutions for society​.

Red Cedar Ventures is the venture investment subsidiary of the Michigan State University (MSU) Foundation. It focuses on providing early-stage funding to startups emerging from MSU’s research and entrepreneurial ecosystem, as well as other high-tech companies in Michigan. With the aim of driving economic impact in the region, Red Cedar Ventures supports innovation by helping to bridge critical funding gaps for startups, offering both pre-seed and growth-stage investments. The firm manages several funds, including a Pre-Seed Fund, Opportunity Fund I and II, and Michigan Rise Pre-Seed Fund III. These funds target startups at different stages of development, providing them with the capital needed to scale. Red Cedar Ventures also partners closely with Spartan Innovations and supports the Conquer Accelerator program, offering selected startups access to investment, mentorship, and resources to help them grow beyond the early phases. The firm’s investments span a wide range of industries, from AI to healthcare and cybersecurity, supporting startups like DeepView (smart cameras for factory inspections) and Flightpath Biosciences (therapies for pathogen-based diseases). With its roots in MSU, Red Cedar Ventures plays a key role in fostering innovation and entrepreneurship throughout Michigan.

Red Sea Ventures is a New York-based venture capital firm that focuses on early-stage investments. They primarily invest in technology-driven companies across sectors such as consumer products, fintech, healthtech, and real estate tech. Notable portfolio companies include Coinbase, Warby Parker, and Sweetgreen, showcasing their commitment to innovative and disruptive startups. Red Sea Ventures emphasizes a hands-on approach, working closely with founders to provide strategic guidance and operational support. They typically participate in Seed and Series A rounds, often leading these investments with check sizes ranging from $500k to $5 million. Their goal is to back visionary entrepreneurs who have the potential to build scalable businesses. Founded by Scott Birnbaum, Red Sea Ventures prides itself on a team of experienced professionals who bring a mix of entrepreneurial, operational, and investment expertise. They focus on the U.S. market, with a particular interest in the vibrant startup ecosystem of New York City. Entrepreneurs seeking investment from Red Sea Ventures are encouraged to have a clear and compelling business plan that demonstrates significant market opportunity and potential for growth. Warm introductions and referrals are preferred when approaching the firm, as they value strong, trusted networks.

Red Tree Venture Capital is a prominent West Coast-centric, early-stage life science venture firm founded in 2020 by Heath Lukatch, Ph.D., and Jennifer Cochran, Ph.D., with managing director Jon Edwards, Ph.D. The firm raised $272 million for its inaugural fund in 2022, focusing on groundbreaking therapeutics in oncology, neurology, and immunology​. Red Tree's notable investments include Acrigen Biosciences, Alladapt Immunotherapeutics, and Ceribell, all leading innovators in gene editing, immunotherapies, and neuromodulation technologies. The firm’s strategy leverages deep relationships with top West Coast academic institutions, including Stanford and UCSF, to source pioneering scientific advancements. Red Tree predominantly leads or co-leads investment rounds, emphasizing first-in-class and best-in-class therapeutics. The firm’s leadership team, with over 60 years of combined experience, is well-versed in translating scientific innovations into successful businesses. They are supported by a scientific advisory board comprising academic luminaries and experienced biopharma executives. The firm’s investment approach is built on four pillars: a focus on West Coast innovation, early-stage investments, targeting transformative therapeutics, and concentrating on oncology, neurology, and immunology. This strategic framework positions Red Tree as a key player in advancing life science innovations that have the potential to significantly impact patient care​.

Redalpine is a leading venture capital firm based in Zurich, Switzerland, specializing in seed and early-stage investments in technology and health tech sectors. Founded in 2007, Redalpine has built a robust portfolio, investing in companies that aim to bring innovative solutions to market. Notable investments include Proxima Fusion, a startup developing next-generation fusion power plants, and Infinite Roots, a pioneer in sustainable food tech focused on mycelium fermentation, which recently raised $58 million in a record-breaking Series B round. Redalpine's investment strategy centers on supporting groundbreaking ideas with potential for significant societal impact, providing both financial backing and operational expertise. Redalpine has been instrumental in several successful exits, such as Lunaphore and natif.ai, and maintains a strong presence in Europe with additional offices in Berlin and Munsbach. The firm typically invests between CHF 500,000 to CHF 5 million per company, focusing on scalable and disruptive technologies. Led by partners like Michael Sidler, Peter Niederhauser, and Nicolas Berg, Redalpine is committed to co-creating a better future with its portfolio companies by offering deep industry knowledge, strategic support, and access to a vast network of experts and partners.

REDO Ventures, founded in 2017 and based in New York, is an early-stage venture capital firm focused on backing transformative consumer technology startups. The firm’s mission is to partner with exceptional entrepreneurs early in their journey to build companies that can reshape industries. REDO Ventures has a particular focus on businesses within sectors such as personal products, retail, healthcare, and software. The team provides hands-on support to their portfolio companies, leveraging their extensive entrepreneurial and operational experience. Their portfolio includes innovative brands like Ellis Brooklyn, a sustainable luxury fragrance company, Thursday Boots, a direct-to-consumer footwear brand, and Alchemy 43, a beauty company specializing in aesthetics treatments. REDO Ventures prides itself on being deeply involved in its investments, offering more than just capital by providing strategic guidance, operational expertise, and global networking opportunities. The firm’s leadership team includes Philippe Glessinger, a founding partner with a background in private equity at Vestar Capital Partners, and Lusa Zhou, a partner with significant experience from Monogram Capital Partners and The Carlyle Group. Together, they bring a wealth of knowledge in scaling consumer-focused brands and driving long-term growth. REDO Ventures is driven by a belief in transparency, risk-taking, and taking a long-term view on entrepreneurship, making them a trusted partner for founders looking to make a significant impact in their industries.

Redpoint Ventures, a prominent venture capital firm founded in 1999, is known for backing innovative startups across various stages, from seed to growth. The firm has made significant investments in leading tech companies like Netflix, Stripe, Snowflake, and Twilio, reflecting its focus on high-potential ventures in consumer, enterprise, and emerging technologies​​. Redpoint's industry focus includes software services, cloud computing, fintech, healthcare, and next-gen media. Their strategy emphasizes early-stage investments, partnering with entrepreneurs to create new markets and redefine existing ones. With an average investment round size of around $1 million, Redpoint typically takes an active role in leading these rounds, offering not just capital but strategic support​​. Geographically, Redpoint Ventures operates mainly out of the United States but has a strong presence in China through Redpoint China Ventures, which focuses on consumer and frontier tech startups​. Key team members include Jeff Brody, who co-founded the firm, and Logan Bartlett, a General Partner known for his expertise in early-growth investments. Their team is based in Menlo Park, California, and they are deeply involved in guiding startups towards successful exits, as evidenced by their numerous high-profile IPOs and acquisitions​​. For startups aiming to catch Redpoint's attention, it’s crucial to present innovative, scalable solutions and a strong market potential. They prefer approaches that showcase clear strategic alignment with their investment focus areas and demonstrate the potential for substantial growth and market impact

Redstone VC is a Berlin-based venture capital firm that focuses on early-stage investments, particularly in sectors like fintech, medtech, deep tech, and green tech. Founded in 2014, the firm takes a data-driven approach to its investments, utilizing its proprietary SOFIA platform to make informed decisions. Redstone typically invests between €1.5 million and €3 million, focusing on Series A and B rounds. The firm operates with specialized investment teams for each strategy, giving it deep sector expertise and the ability to build strong networks across industries. Redstone’s portfolio includes companies such as Finanzguru, Liqid, and Flyability, with successful exits like Marley Spoon and Penta. They emphasize supporting startups that contribute to positive societal change, with particular attention to sustainability, health, and industrial innovation. Redstone’s goal is to not only provide capital but also strategic mentorship, helping entrepreneurs scale and navigate challenges through active partnerships. With a presence across Germany, Redstone is a key player in Europe’s venture capital landscape, known for its commitment to impactful investments and long-term growth.

Refactor Capital, founded in 2016 by Zal Bilimoria, is a seed-stage venture capital firm based in Burlingame, California. The fund primarily focuses on bio, climate, and hard tech innovations, aiming to support startups that tackle fundamental human and planetary health challenges. Notable investments include Solugen, Astranis, and Notable Labs, showcasing their dedication to transformative technologies in fields like sustainable chemicals, space, and healthcare. Refactor Capital typically leads or co-leads seed rounds, with investment amounts ranging from $1M to $2M. The firm values quick decision-making and close founder relationships, providing extensive support beyond capital, such as CFO services, communications training, and mental fitness resources. This hands-on approach is integral to their strategy, ensuring startups receive comprehensive guidance and resources. Geographically, Refactor Capital focuses on the U.S., with a significant portion of their portfolio companies based in California. They prefer to invest in startups that demonstrate clear potential to disrupt and innovate within heavily regulated industries, making technologies more accessible and efficient. Zal Bilimoria, the solo partner of Refactor Capital, brings a wealth of experience from his time at Andreessen Horowitz and major tech companies like Google, Netflix, and LinkedIn. His leadership and deep industry connections make Refactor Capital a formidable player in the early-stage investment landscape.

Reinforced Ventures is a Pittsburgh-based venture capital firm that focuses on early-stage investments in deep tech sectors such as robotics, AI, autonomous systems, and biotechnology. Founded in 2019 by Euan Guttridge, the firm actively backs innovative startups leveraging cutting-edge technologies to disrupt industries and solve complex problems. Reinforced Ventures often leads seed and early-stage rounds, targeting companies developing novel solutions in industries like aerospace, mobility, and life sciences. The firm has a strong portfolio, including companies like DAGsHub (a platform for data scientists), Electric Sheep Robotics (offering autonomy-as-a-service for lawn care), and Lemurian Labs (developing solutions for autonomous edge systems). Their geographic focus includes North America and select global markets, with investments spanning key hubs like Pittsburgh, San Francisco, and Toronto. Reinforced Ventures’ strategy centers on investing in scalable companies that combine hardware and software innovations, particularly those addressing critical challenges in automation, AI, and biotech. With over 65 investments, they continue to partner with visionary founders to accelerate technological advancements.

Remiges Ventures is a US-Japan cross-border life-sciences venture capital firm founded in 2014 with offices in Seattle, Washington and Tokyo, Japan. The firm invests in early-stage drug discovery and therapeutic development companies and is distinguished by deep connections to Japanese academic medical research and the Japanese pharmaceutical industry, giving portfolio companies strategic access to Japanese partnering, clinical development pathways, and licensing opportunities alongside US and global scale. Remiges is led by Founder, Managing Partner and Managing Director Taro Inaba and is a SEC-registered investment adviser. Remiges has raised two biopharma funds. Remiges BioPharma Fund II closed in April 2021 at a final $95 million and attracted a strategic LP base including Taiho Pharmaceutical, Sumitomo Dainippon Pharma, Bristol-Myers Squibb, 1Globe Capital, EA Pharma, and Senju Pharmaceutical. The firm makes minority investments at seed, early-stage, and later-stage rounds, typically alongside strategic pharma syndicates. Alongside its investment activity, Remiges launched RDiscovery, a life-sciences incubator focused on advancing early-stage therapeutic concepts through company creation. The portfolio has expanded to 15 active companies. Notable investments include Glycomine (PMM2-CDG Phase 2 therapeutic, where Remiges led a Series C follow-on in April 2025), Restore Vision (Series A with first-in-human data in 2024), Eurus Therapeutics, Ride Health, KUPANDO, and Capacity Bio. The firm made 2 new investments in 2024 and at least 2 in 2025. Remiges occupies a distinct cross-border niche: its pharma LP base creates structural alignment between investor interests and portfolio company commercial development, while its Tokyo presence provides a genuine channel to Japanese clinical partnerships that pure US-based life-sciences funds cannot replicate.

Renewal Funds is a mission-driven venture capital firm based in Vancouver, Canada, focusing on early growth-stage investments in environmental technology and sustainable consumer products. With approximately $240 million in assets under management across three funds, Renewal Funds has a dual-sector strategy that emphasizes both environmental innovation and sustainable consumer products. This approach leverages cross-sector synergies and diversification to drive both environmental and social impact while delivering above-market returns for investors. Founded by Paul Richardson, Joel Solomon, and Carol Newell, the firm has a long history of mission-led investing. The team at Renewal Funds brings extensive experience in finance, legal, sustainability, and impact investing. Notable investments in their portfolio include Caboo Paper Products, Hodo Foods, and Tru Earth, which focus on innovative, eco-friendly solutions that address significant environmental challenges. Renewal Funds typically invests in companies with North American headquarters, at least $1 million in annual revenue, a scalable business model, and significant environmental and social impact. They provide more than just capital, offering strategic support, access to networks, and industry expertise to help their portfolio companies grow and succeed.

Reshape Ventures is a boutique early-stage investment firm based in New York City, founded in 2015. The firm has made over 200 investments, focusing on proptech, retail and e-commerce, and healthcare sectors. They support innovative startups from their early stages, helping them scale and succeed in competitive markets. Reshape Ventures' portfolio includes a variety of successful companies such as SoFi, Sweetgreen, and Flexport. In recent years, they've invested in companies like Grow Therapy, Betterleap, and Vivanterre, showcasing their continued commitment to backing high-potential startups. The firm is led by Managing Partner Vinay Menda, with key team members including Emir Ildiz, Partner & COO, and Brian DeRosa, Investor. They emphasize a collaborative approach, working closely with founders to provide not just capital, but also strategic guidance and industry connections.

Resolute Ventures, founded in 2011, is a venture capital firm based in San Francisco, California. The firm focuses on seed-stage investments, backing extraordinary entrepreneurs across various sectors including consumer, data, developer tools, e-commerce, enterprise, financial services, technology, hardware, software, and marketplaces. Notable investments include companies like Greenhouse Software, Reonomy, Clutter, and Whoop. The firm has made over 160 investments and has seen around 77 exits, with companies like Influitive and Signifyd reaching significant milestones. Resolute Ventures prides itself on being highly entrepreneur-focused, often investing at the earliest stages before other investors come in. This approach allows them to make quick investment decisions and offer substantial support to startups from the ground up. The team is led by co-founders Michael Hirshland and Raanan Bar-Cohen, who bring a wealth of experience and a hands-on approach to their investment strategy. The firm's recent investments include Bolden Therapeutics and SGNL, indicating their ongoing commitment to innovation and growth in various tech sectors. For startups seeking a dedicated and proactive investment partner, Resolute Ventures offers a robust combination of expertise, rapid decision-making, and a strong support network to help entrepreneurs succeed.

Rethink Capital Partners is an impact-focused investment firm that manages a diverse array of strategies aimed at generating both financial returns and positive social and environmental impact. As part of Seavest Investment Group, Rethink Capital Partners oversees several funds, including Rethink Education, Rethink Food, and Rethink Impact, each targeting different sectors. Founded with the mission of leveraging capital to drive systemic change, Rethink Capital Partners has invested in various sectors including education technology, food technology, and gender equity. The firm has a strong emphasis on diversity, with a significant portion of its investments in women-led and minority-led companies. They are pioneers in impact investing, often ahead of market trends, and focus on businesses that address critical societal challenges. Notable additions to their team include Amy Nelson, Chief Strategy Officer, and Alison Smith, Partner, who bring substantial expertise and networks to the firm. Their roles focus on growing Rethink’s strategies and expanding their impact.

Rev1 Ventures is a prominent venture development studio based in Columbus, Ohio, dedicated to fostering startup growth in the Midwest. Managing over $130 million in capital, Rev1 supports startups from pre-seed through early-stage funding, with a strong emphasis on enterprise software and life sciences. Notable investments include Updox, MentorcliQ, and Aware​​. Rev1's strategy involves not only providing capital but also offering comprehensive support through its startup studio model. This includes access to corporate connections, top talent, and a robust mentor network. The studio's innovative approach has helped launch more than 150 startups and supported 70+ successful exits​. The firm recently launched several funds, including the $10 million Future Value Fund I, aimed at pre-seed investments, and the $20 million Rev1 Fund II, which supports high-growth companies in digital health, fintech, and more​. Rev1's investments are geared toward sectors like AI, digital health, and SaaS, with a focus on startups that are underserved by traditional venture capital​​. Rev1's team, led by CEO Tom Walker, brings a wealth of experience in scaling startups and driving innovation. The firm collaborates closely with Ohio State University and other local institutions to leverage regional strengths and support technology commercialization​​. Rev1 Ventures is committed to making Central Ohio a thriving hub for high-growth startups, combining strategic services with substantial funding to ensure long-term success and regional economic impact​.

Revo Capital is a leading venture capital firm based in the Netherlands, with a significant presence in Turkey, Eastern Europe, and the Baltics. The firm was established with the aim of empowering local entrepreneurs to unlock global potential, focusing on early-stage B2B and B2C technology ventures. Since its inception in 2013, Revo Capital has raised substantial funds, including a $66 million inaugural fund and a €90 million second fund, investing in over 40 startups​ (Revo)​​ (Revo)​. Revo Capital typically looks for startups with strong teams, customer validation, and market traction. They prefer to be early believers in their investments, often leading or co-leading funding rounds. The firm is known for its hands-on approach, providing support in areas such as marketing, finance, team building, business development, and fundraising​. Their portfolio includes notable companies like Getir, Builder.ai, and Midas, spanning various sectors including fintech, big data, AI, cybersecurity, health IT, and commerce enablers​ (Revo)​. Revo Capital's team is led by experienced professionals such as Cenk Bayrakdar and Berkin Toktaş, both of whom have extensive backgrounds in telecom and product strategy at Turkcell​.

Revolution LLC, founded in 2005 by AOL co-founder Steve Case, is a Washington, D.C.-based investment firm that focuses on building transformative companies. The firm operates three main investment funds: Revolution Ventures, Revolution Growth, and the Rise of the Rest Seed Fund. Revolution Ventures targets early-stage technology investments under $10 million. Revolution Growth, launched with an initial capital of $450 million, focuses on growth-stage investments of $10 million and above in consumer technology businesses. Notable investments from Revolution Growth include Sweetgreen, Bigcommerce, and DraftKings​. The Rise of the Rest Seed Fund is particularly unique, as it aims to invest in startups located outside the traditional tech hubs of Silicon Valley, New York, and Boston. This initiative has seen over 200 investments across more than 100 U.S. cities, supported by prominent investors like Jeff Bezos and the Walton Family​. Some of the high-profile companies in Revolution’s portfolio include Zipcar, LivingSocial, Tempus, and CLEAR. Revolution's investment strategy is guided by a mission to support entrepreneurs who are disrupting legacy industries with innovative solutions.

Rhapsody Venture Partners is a venture capital firm based in Cambridge, Massachusetts, specializing in early-stage investments in hard-tech innovations. Founded in 2012, Rhapsody focuses on technologies such as new materials, engineering innovations, chemistries, and food tech, helping to bring these innovations from the lab to the market. The firm has a unique approach, recognizing the challenges traditional VC funds face when investing in scientific innovations. Rhapsody positions itself as a partner for scientific founders, providing both capital and co-creation support. Their investments span multiple sectors, including energy, advanced materials, life sciences, and industrial technologies. Notable portfolio companies include Tender Food, which is developing plant-based meats; NODAR, focused on autonomous transportation safety; and Sensatek, which creates high-temperature sensors for industries like energy and aviation. Rhapsody is known for its strategic partnerships and hands-on involvement in the growth and development of its portfolio companies​.

Rhia Ventures is a forward-looking impact investment firm focused on reshaping the U.S. market for sexual, reproductive, and maternal health. Through its flagship fund, RH Capital, Rhia Ventures invests in early-stage companies dedicated to advancing health equity for underserved groups. Their investments span key areas like contraception, maternal care, diagnostics, digital health, and consumer health, emphasizing innovations that can transform access and outcomes in women's health. Notable in its approach, RH Capital employs the proprietary HEART Framework, which rigorously assesses a company’s commitment to health equity across race, gender, socioeconomic factors, and health outcomes before investing. Rhia Ventures’ leadership team is mission-driven, led by CEO Erika Seth Davies, a pioneer in impact investing and founder of the Racial Equity Asset Lab, known for her work in addressing racial disparities in wealth and health. COO Keisha Leverette brings deep expertise in philanthropic development, while Sonia Sarkar, Director of Ecosystem Building, has extensive experience in health equity and community mobilization. Together, the team uses a high-touch approach, engaging actively with portfolio companies to instill values of inclusivity and advocacy for reproductive health in business strategy. Based in the U.S., Rhia Ventures operates with an impact-first mindset, investing at the intersection of profitability and social good. They target founders whose solutions advance meaningful change in healthcare, providing support beyond capital, including corporate advocacy and coalition building. Startups seeking investment should demonstrate a strong alignment with Rhia’s mission and be ready to incorporate health equity principles into their growth models.

Ribbit Capital is a global venture capital firm with a singular mission: to transform the world of finance. Founded in 2012, Ribbit focuses on investing in companies that aim to innovate and disrupt traditional financial services. The firm invests in a range of sectors, including lending, personal finance, insurance, financial software, and cryptocurrency. Ribbit Capital is known for its deep understanding of the complexities of building financial businesses. The firm emphasizes not just financial investment but also sharing its extensive experience and insights with the entrepreneurs it backs. Ribbit's investment philosophy is centered on the belief that consumers and business owners moving to mobile will significantly impact financial services for decades to come, favoring new entrants and brands over legacy players. The team at Ribbit Capital includes experienced professionals like founder and managing partner Meyer “Micky” Malka, who has a background in financial services across multiple continents. Other key team members include Denise Gilbert, Nick Shalek, and Sigal Mandelker, each bringing a wealth of expertise to support the firm's mission. Ribbit Capital has a diverse portfolio that includes companies like Coinbase, Affirm, and Robinhood, reflecting its commitment to backing ambitious entrepreneurs who are poised to reshape the financial landscape.

Ridge Ventures is an early-stage venture capital firm specializing in Seed and Series A investments, particularly in enterprise software companies. The firm, founded in 2007, backs experienced entrepreneurs who are redefining how we interact with data and code. Ridge Ventures is known for investing in high-potential startups like Discord, Fastly, and Braze, with a focus on companies that deliver advanced technology and create strong customer experiences. The firm's strategy revolves around building long-term partnerships with founders, emphasizing transparency and alignment. Ridge typically writes checks between $2M to $7M, helping companies achieve product-market fit and scale revenue systems through its extensive Ridge Revenue Network, which includes Fortune 500 CXOs. Ridge takes a hands-on approach, actively helping portfolio companies connect with customers to accelerate revenue generation. Based in San Francisco, Ridge is passionate about substance over hype, backing founders who prioritize strong business fundamentals and are ready to scale their ventures. The firm is led by key figures like Managing Partner Alex Rosen, and has recently added partners like Akriti Dokania to strengthen their focus on enterprise software​.

Right Side Capital Management (RSCM), based in San Francisco, is a venture capital firm specializing in pre-seed stage investments in technology startups. Since its inception in 2010, RSCM has focused exclusively on pre-seed funding, making it their primary investment stage. They have an extensive portfolio with over 1,000 investments, showcasing their commitment to early-stage ventures​. RSCM's investment strategy is systematic and data-driven, targeting startups across various tech sectors, including SaaS, AI, and biotech. They typically invest between $100K and $300K per company, with total round sizes ranging from $100K to $500K. The firm prefers startups that have achieved some traction, usually generating $5K to $30K in monthly gross profit​. Notable investments by RSCM include DigitalOcean, ClassPass, and Upsie, reflecting their success in identifying high-potential startups early on. They have a strong track record, with 201 exits from their portfolio, highlighting their effectiveness in supporting startups to successful outcomes​. The leadership team at RSCM includes Managing Directors Dave Lambert, Kevin Dick, and Jeff Pomeranz, each bringing a wealth of experience in entrepreneurship, technology management, and private equity. This experienced team focuses on providing hands-on support and quick investment decisions, ensuring a founder-friendly approach​​. RSCM's geographic focus primarily includes the United States and Canada, with occasional investments in Western Europe, Israel, Australia, and New Zealand. Their investment philosophy emphasizes capital-efficient business models that can achieve significant returns even with smaller exit values​.

Root Ventures, founded in 2013 and headquartered in San Francisco, is a seed-stage venture capital firm that focuses on investing in deep tech startups. The firm emphasizes supporting technical teams working on groundbreaking innovations across various sectors, including hardware, software, and biotechnology. Root Ventures has a diverse portfolio, with notable investments in companies like Stellar Pizza, a robotics company acquired in 2024; Nautilus Labs, a maritime analytics platform; and TruckLabs, which offers tech-enabled solutions for the trucking industry. Other significant investments include Shaper Tools, a provider of digital tools for the construction industry, and Daily, a video conferencing solution. The firm has made 114 investments and achieved 16 successful exits, demonstrating their ability to identify and nurture promising startups. Root Ventures is led by a team of experienced partners, including founding partner Avidan Ross, Chrissy Meyer, Kane Hsieh, and Lee Edwards. They focus on providing not only capital but also strategic guidance and support to help their portfolio companies succeed.

RC Capital, also known as River Cities Capital, is a growth equity firm focused on building high-potential healthcare companies. Based in Cincinnati, Ohio, and Raleigh, North Carolina, RC Capital leverages its expertise in three key segments: medical devices, healthcare services, and healthcare IT. The firm's investment strategy is centered on enhancing patient outcomes by supporting companies that enable clinicians to improve care delivery and efficiency. With over $500 million in assets under management across multiple funds, RC Capital has a strong track record in the healthcare sector. The firm's portfolio includes companies that provide innovative solutions in diagnostics, remote patient monitoring, and minimally invasive surgical technologies. Some notable investments include Suros Surgical, Orthoscan, and StepLeader. RC Capital's latest fund, Fund V, closed at $200 million, surpassing its $150 million target. This fund continues the firm's strategy of investing in underserved growth equity rounds, supporting companies that combine disruptive technologies with innovative business practices.

RiverPark Ventures, founded in 2006 by Andy Appelbaum and Morty Schaja, is an early-stage venture capital firm based in New York City. The firm is known for investing in high-growth, disruptive businesses with innovative products and services. They focus primarily on sectors such as B2B, fintech, consumer, and proptech, targeting companies with proven business models and preliminary revenue generation. RiverPark Ventures has a robust portfolio, including notable investments in companies like Thrasio, Slice, Petal, Via, and Candid. They typically make initial investments ranging from $500,000 to $1.5 million, and growth checks from $1 million to $25 million. Their investment strategy emphasizes the importance of great leadership, sharp focus on large market opportunities, and a preference for capital-efficient businesses that leverage technological advantages. The firm benefits from its affiliation with RiverPark Funds, which manages over $3 billion in assets across various strategies. This relationship provides RiverPark Ventures with access to extensive research capabilities and industry contacts, enhancing their ability to source and support investments. RiverPark Ventures has had numerous successful exits, including companies like Relay Delivery, Thrasio, and Fuzzy, highlighting their effectiveness in nurturing startups towards successful outcomes.

Riyad Taqnia Fund (RTF) is a venture capital fund based in Saudi Arabia, founded in 2016 by Riyad Capital and Taqnia. Focused on early-stage technology companies, RTF targets post-revenue opportunities from Seed to Series B rounds. Its investment sectors include enterprise applications, fintech, logistics, and consumer tech. The fund primarily invests in companies across the Middle East and North Africa (MENA) region, particularly in Saudi Arabia and the UAE, with a few investments in other countries like Indonesia and the UK. RTF has built a strong portfolio over the years, investing in companies like TruKKer, a digital freight platform, and Haseel, a food and agriculture tech company. With check sizes ranging from $1M to $20M, the fund seeks startups that offer innovative solutions capable of scaling across the region. Its approach emphasizes both financial returns and strategic industry partnerships. RTF operates with a long-term view, providing not only capital but also leveraging its extensive network of co-investors and institutional backers. This makes it a key player in the MENA startup ecosystem, especially for founders looking to scale quickly in sectors like fintech and logistics. The fund is ideal for growth-stage companies looking for a strong partner to help them navigate the complexities of the regional market.

Robert Bosch Venture Capital GmbH (RBVC), founded in 2007, is the corporate venture capital arm of the Bosch Group. Based in Stuttgart-Weilimdorf, Germany, RBVC focuses on investing in innovative technology startups globally, covering early to late-stage investments. Their investment strategy spans multiple sectors, including automation, electrification, mobility solutions, healthcare, energy efficiency, artificial intelligence (AI), Internet of Things (IoT), and advanced computing technologies. RBVC has a diversified portfolio with notable investments in companies such as Aleph Alpha, an AI startup, and AnyClip, a multimedia and design software company. They have also invested in startups like Graphcore, which develops intelligent processing units for AI workloads, and IOTA, which focuses on blockchain-based M2M payments​. The firm typically invests between €3-5 million in initial financing rounds, with the potential to invest up to €15 million in total per company. Additionally, RBVC selectively provides seed capital and participates in other venture capital funds to build a robust international and industrial network​. RBVC's investments have led to several successful exits, including the acquisitions of companies like Foghorn by Johnson Controls and GreenPeak by Qorvo. They are known for leveraging Bosch's extensive network to help startups scale and establish new business models, often fostering co-innovation through the Open Bosch Program.

Rocana Ventures is a purpose-driven venture capital firm based in Los Angeles, specializing in early-stage investments in consumer brands that promote health and wellness. With a focus on the "Better Living" sector, Rocana's investment strategy centers on food and beverage, personal care, and mind-body wellness, aiming to democratize wellness and make it accessible to the broader market. They steer clear of industries like tobacco, alcohol, and non-CBD cannabis, aligning their investments with a triple bottom line approach: people, planet, and profit. Rocana's portfolio includes notable brands like Olipop, a digestive health soda, and Good Catch, a plant-based seafood alternative, highlighting their commitment to sustainable and health-conscious consumer products. The firm provides not just capital, but also extensive support in brand building, go-to-market strategy, and global distribution, leveraging their network of industry experts and strategic partners. Led by founders Gurdeep Prewal, Sumesh Sachar, and Alex Borschow, who bring a wealth of experience from diverse global markets, Rocana Ventures is uniquely positioned to help brands scale and thrive in the competitive wellness industry. They are particularly interested in products that offer functional benefits, organic and non-GMO credentials, and innovative approaches to personal wellness.

The Roche Venture Fund is the corporate venture capital arm of Roche, a global leader in healthcare and pharmaceuticals. With an evergreen fund of CHF 750 million, the fund focuses on investing in life sciences, particularly in pharmaceuticals, diagnostics, and digital health sectors. The fund’s mission is to foster innovation and build commercially successful companies while generating financial returns for Roche. They typically make Series A investments, with initial checks ranging from CHF 5-10 million and a 15-20% equity stake. Roche Venture Fund is active globally, with offices in Basel, Switzerland, and South San Francisco, USA, providing access to a wide network of industry experts and strategic guidance to portfolio companies. Notable investments include companies like Freenome, Black Diamond Therapeutics, and Syapse, which are leaders in fields like diagnostics and precision medicine. The fund offers more than just financial backing, involving themselves deeply in the growth and development of their portfolio companies. This hands-on approach ensures startups benefit from Roche’s vast resources and expertise in navigating the complexities of the life sciences market. Their long-term vision and commitment to innovation make them a preferred partner for biotech and healthtech startups looking to make a significant impact.

Rock Health Capital is a prominent venture capital firm based in San Francisco, focusing on investments in early-stage companies at the intersection of healthcare and technology. Founded in 2010, Rock Health aims to make healthcare more accessible and effective by supporting entrepreneurs with innovative solutions that address critical health challenges. The firm invests in a variety of sectors within digital health, including clinics/outpatient services, healthcare services, AI, analytics, and cloud infrastructure. Their portfolio includes companies like Omada Health, Doctor On Demand, and Evidation Health, reflecting their commitment to transformative healthcare solutions. Rock Health Capital offers more than just funding; they provide strategic guidance, market insights, and a robust network of healthcare professionals and corporate partners. This support helps startups navigate the complex healthcare landscape and scale their innovations effectively. Key team members include Bill Evans, Founder and General Partner, and Tom Cassels, CEO, who bring extensive experience and expertise in healthcare and technology.